CN105092754A - Method for determining sulfonate genotoxic impurity by using HPLC - Google Patents
Method for determining sulfonate genotoxic impurity by using HPLC Download PDFInfo
- Publication number
- CN105092754A CN105092754A CN201410215531.2A CN201410215531A CN105092754A CN 105092754 A CN105092754 A CN 105092754A CN 201410215531 A CN201410215531 A CN 201410215531A CN 105092754 A CN105092754 A CN 105092754A
- Authority
- CN
- China
- Prior art keywords
- damping fluid
- organic phase
- volume ratio
- ratio
- during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a method for determining sulfonate genotoxic impurity (or suspected genotoxicity) by using HPLC. According to the invention, octadecylsilane chemically bonded silica is taken as a chromatographic column of a stationary phase, a mixed solvent of an organic phase and a buffer is performed with gradient elution to be taken as a mobile phase for direct detection. The detection method has the advantages of high sensitivity, strong specialization, high precision, strong accuracy and convenient operation; and the method has wide applicability and can effectively control the quality of the bulk drugs.
Description
Technical field
The invention belongs to Pharmaceutical Analysis field, particularly, relate to one and utilize HPLC(high performance liquid chromatography) measure the method for sulfonic acid esters genotoxicity impurity.
Background technology
In pharmaceutical synthesis, methane-sulforic acid, the sulfonic acid substances such as benzene methanesulfonic acid generate alkyl sulfonic ester as methyl mesylate (MMS) with the lower alcohol of trace in synthetic reaction, ethyl methane sulfonate (EMS), normal-butyl methanesulfonates (NBMS), and aromatic yl sulphonate is as methyl benzene sulfonate (MBS), ethyl benzenesulfonat (EBS), p-toluenesulfonic acid ester (MP-TS), alkylated reaction can be there is in these materials with DNA, thus the inducement of cause cancer may be become, the existence of these latent gene toxic impurities causes the great attention of management organization, be defined in bulk drug the strict control carrying out related substance, European Union specify the limit of genotoxicity impurity be maximum day dosing be 1.5 μ g.
Exist in prior art and use HPLC method to measure sulfonic acid esters impurity, HPLC-UV method is the detection method relatively commonly used, as PR-HPLC method measures MBS, EBS in Amlodipine Besylate Tablet, the method adopts InretsilODS chromatographic column (150mm × 4.6mm, 5 μm), mobile phase is 1% triethylamine (Ph3.0)-acetonitrile, its degree of separation and peak shape are better, but detectability is lower, and when measured object concentration is lower, uv absorption may not be detected, thus impact measures.
At present, the sensitivity of China's conventional medicine determination method is only 10 to 60ppm, the analysis of quantitative and qualitative analysis cannot be carried out at all to genotoxicity impurity, by the continuous adjustment of synthetic route, intermediate and the starting material that may produce genotoxicity impurity can only be avoided.
Applicant finds, be the chromatographic column of Stationary liquid in order to octadecylsilane chemically bonded silica, the mixed solvent of organic phase and acetate buffer is as eluent gradient wash-out, sulfonic acid esters impurity can be detected, and highly sensitive (sensitivity can reach 0.75ppm), can effectively control bulk drug quality, solve genotoxicity cannot qualitative and quantitative analysis detect a difficult problem.
Summary of the invention
The invention provides a kind of method utilizing HPLC to measure sulfonic acid esters genotoxicity impurity, thus realize the control of trace sulfonic acid esters genotoxicity impurity in bulk drug.
Technical scheme of the present invention: a kind of method utilizing HPLC to measure sulfonic acid esters genotoxicity impurity is provided,
Selection octadecylsilane chemically bonded silica is Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out.
Detecting step is as follows:
(1) set chromatographic condition: chromatographic column with octadecylsilane chemically bonded silica as Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out, column temperature 20 DEG C ~ 30 DEG C, flow velocity is 0.8 ~ 1.2mL/min, and determined wavelength is 260nm ± 10nm;
(2) sample solution is prepared: adopt the mixed liquor of organic solvent or organic solvent and water that detected sample is mixed with sample solution;
(3) compartment analysis: by sample solution 10 μ L, injects high performance liquid chromatograph, completes the mensuration of sulfonic acid esters genotoxicity impurity.
Described organic phase is for being selected from acetonitrile.
Described damping fluid is that acetate rushes liquid.The concentration range of damping fluid is 0.005mol/L ~ 0.05mol/L, preferred 0.01mol/L.
The pH value of described damping fluid is 3.0 ~ 5.1.
Described mobile phase is the mixed solvent gradient elution of organic phase and damping fluid, and during gradient elution 0 ~ 5min, the ratio of damping fluid, organic phase is volume ratio 90%:10%; During 5 ~ 14min, damping fluid volume ratio is reduced to 80%, and organic phase volume ratio increases to 20%; 14 ~ 15min, buffer ratio is that volume ratio is reduced to 10%, and the ratio of organic phase is volume ratio when increasing to 90%:15 ~ 25min, and the ratio of damping fluid, organic phase is that volume ratio 10%:90% is constant; During 25 ~ 30min, damping fluid volume ratio increases to 90%, and organic phase volume ratio is reduced to 10%; During 30 ~ 35min, the ratio of damping fluid, organic phase is that volume ratio 90%:10% is constant.
Described testing conditions: column temperature 20 DEG C ~ 30 DEG C, preferably 25 DEG C; Flow velocity is 0.8 ~ 1.2mL/min, preferably
1.0mL/min。Determined wavelength is 260nm ± 10nm, preferred 260nm.
Detection method of the present invention, can realize according to following methods:
(1) get detected sample appropriate, dissolve with the mixed solvent of acetonitrile or it and water, be mixed with the sample solution of suitable concn.
(2) get sulfonic acid esters impurity appropriate, dissolve with the mixed solvent of acetonitrile or it and water, be mixed with the reference substance solution of suitable concn.
(3) arranging flow rate of mobile phase is 0.8 ~ 1.2mL/min, and the flow velocity of mobile phase is preferably 1.0mL/min; Detect
Wavelength 260nm; Chromatogram column temperature is 20 DEG C ~ 30 DEG C, is preferably 25 DEG C.
(4) get respectively (1), 2) sample solution and reference substance solution 10 μ L, inject high performance liquid chromatograph, complete the assay of sulfonic acid esters toxic impurities.
Technique effect of the present invention: by utilizing HPLC, carry out trace detection analysis to genotoxicity impurity in bulk drug (or doubtful genotoxicity) sulfonic acid esters toxic impurities, sensitivity can reach 0.75ppm.
Embodiment
Be described below in detail embodiments of the invention, it should be noted that embodiment described below is exemplary, only
For explaining the present invention, and limitation of the present invention can not be interpreted as.In addition, if do not clearly not stated, adopted in the following embodiments all reagent are, and market can be buied, or can according to text or the synthesis of known method, for the reaction conditions do not listed, be also that those skilled in the art easily obtain.
Embodiment 1
Instrument: Agilent1260 high performance liquid chromatograph, 1260 UV-detector
Chromatographic column: octadecylsilane chemically bonded silica is the chromatographic column (250 × 4.6mm, 5 μm) of filling agent;
The ammonium acetate buffer (pH5.1) of mobile phase A: 0.01mol/L
Mobile phase B: acetonitrile
Gradient elution sees the following form;
Flow velocity: 1.0mL/min
Determined wavelength: 260nm
Column temperature: 25 DEG C
Sampling volume: 10 μ L
Thinning agent: acetonitrile
Test procedure:
Need testing solution: take Amlodipine Besylate Tablet sample 1.0014g and put 10mL measuring bottle, dissolve with thinning agent and be diluted to scale, shaking up.
Reference substance solution: precision takes P-TOLUENE SULFO ACID 99's methyl esters reference substance 7.48mg and puts in 100mL measuring bottle, is diluted to scale by water-soluble solution, shakes up, as stock solution A.Precision measures 1.0mL stock solution A and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, and as stock solution B, precision measures 1.0mL stock solution B and puts in 10mL measuring bottle, is diluted to scale, shakes up with thinning agent, in contrast product solution (0.75ppm).
Get reference substance, need testing solution respectively, under above-mentioned chromatographic condition, carry out efficient liquid phase chromatographic analysis, record chromatogram, the retention time methyl benzene sulfonate chromatographic peak that to be 6.282min chromatographic peak be in figure, adopts area normalization method to calculate impurity content.
Conclusion: the methyl benzene sulfonate in Amlodipine Besylate Tablet sample is less than 0.75ppm.
Embodiment 2
Instrument: Agilent1260 high performance liquid chromatograph, 1260 UV-detector
Chromatographic column: octadecylsilane chemically bonded silica is the chromatographic column (250 × 4.6mm, 5 μm) of filling agent;
The ammonium acetate buffer (pH3.0) of mobile phase A: 0.01mol/L
Mobile phase B: acetonitrile
Gradient elution sees the following form;
Flow velocity: 1.0mL/min
Determined wavelength: 250nm
Column temperature: 20 DEG C
Sampling volume: 10 μ L
Thinning agent: acetonitrile
Test procedure:
Need testing solution: take methane-sulforic acid T-3811 crude product 1.0014g and put 10mL measuring bottle, dissolve with thinning agent and be diluted to scale, shaking up.
Reference substance solution: precision takes methyl mesylate reference substance 37.42mg and puts in 100mL measuring bottle, molten with thinning agent
Separate and be diluted to scale, shaking up, as stock solution A.Precision measures 1.0mL stock solution A and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, and as stock solution B, precision measures 1.0mL stock solution B and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, in contrast product solution (3.75ppm).
Get reference substance, need testing solution respectively, under above-mentioned chromatographic condition, carry out efficient liquid phase chromatographic analysis, record chromatogram, in figure, retention time is 4.545min chromatographic peak is methyl mesylate chromatographic peak, adopts area normalization method to calculate impurity content.
Conclusion: this method is applicable to the content of the methyl mesylate detecting variable concentrations scope in methane-sulforic acid T-3811 sample.
Reference examples 1
Adopt the genotoxicity impurity of GC-FID method P-TOLUENE SULFO ACID 99 Amlodipine of the prior art to carry out detection to analyze, further checking the present invention adopt accuracy and the sensitivity of method.
The preparation of need testing solution: get Amlodipine Besylate Tablet appropriate, accurately weighed, first dissolve by little water, then by acetone diluted and constant volume makes 20mg/ml, as need testing solution; Get methyl benzene sulfonate reference substance appropriate, accurately weighed, also dilute with acetone solution and make 0.05mg/ml solution, product solution in contrast; Get above-mentioned need testing solution and reference substance solution headspace sampling in accordance with the law respectively, record chromatogram, with peak area external standard method result of calculation.
Chromatographic condition:
Injection port: shunting, temperature 250 DEG C;
Chromatographic column: polyglycol is that Stationary liquid or polarity are close;
Column temperature: temperature programme 150 DEG C keep 4 minutes then with 20 DEG C per minute be warmed up to 240 DEG C keep 5 minutes;
Column flow rate: 2.0ml/min;
Detecting device: flame ionization ditector (FID), temperature 280 DEG C;
Split sampling: split ratio 10:1;
Sample introduction pattern: headspace sampling;
Head-space sampler: furnace temperature 150 DEG C insulation 10 minutes, pin temperature 150 DEG C, sample size 1ml.
Define methyl benzene sulfonate according to the appearance time of reference substance solution and need testing solution to exist, and conform to the result that the present invention measures according to the content going out the methyl benzene sulfonate in peak area determination test sample of methyl benzene sulfonate.
Claims (9)
1. utilize HPLC to measure a method for sulfonic acid esters genotoxicity impurity, it is characterized in that:
(1) chromatographic condition: chromatographic column take octadecylsilane chemically bonded silica as Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out, column temperature 20 DEG C ~ 30 DEG C, flow velocity is 0.8 ~ 1.2mL/min, and determined wavelength is 260nm ± 10nm;
(2) preparation of sample solution: adopt the mixed liquor of organic solvent or organic solvent and water that detected sample is mixed with sample solution;
(3) compartment analysis: by sample solution 10 μ L, injects high performance liquid chromatograph, completes the mensuration of sulfonic acid esters toxic impurities.
2. method according to claim 1, is characterized in that: described mobile phase is the mixed solvent gradient elution of organic phase and damping fluid, and during gradient elution 0 ~ 5min, the ratio of damping fluid, organic phase is volume ratio 90%:10%; During 5 ~ 14min, damping fluid volume ratio is reduced to 80%, and organic phase volume ratio increases to 20%; 14 ~ 15min, buffer ratio is that volume ratio is reduced to 10%, and the ratio of organic phase is that volume ratio increases to 90%; During 15 ~ 25min, the ratio of damping fluid, organic phase is that volume ratio 10%:90% is constant; During 25 ~ 30min, damping fluid volume ratio increases to 90%, and organic phase volume ratio is reduced to 10%; During 30 ~ 35min, the ratio of damping fluid, organic phase is that volume ratio 90%:10% is constant.
3. method according to claim 1 and 2, is characterized in that: described organic phase is acetonitrile.
4. method according to claim 1 and 2, is characterized in that: described damping fluid is for being selected from acetate buffer.
5. method according to claim 4, is characterized in that: the concentration range of described damping fluid is 0.005mol/L ~ 0.05mol/L, preferred 0.01mol/L.
6. method according to claim 4, is characterized in that: the pH value of described damping fluid is 3.0 ~ 5.1.
7. method according to claim 1, is characterized in that: the flow velocity of mobile phase is 1.0mL/min.
8. method according to claim 1, is characterized in that: column temperature is 25 DEG C.
9. method according to claim 1, is characterized in that: determined wavelength is 260nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410215531.2A CN105092754B (en) | 2014-05-21 | 2014-05-21 | A method of measuring sulfonic acid esters genotoxicity impurity using HPLC |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410215531.2A CN105092754B (en) | 2014-05-21 | 2014-05-21 | A method of measuring sulfonic acid esters genotoxicity impurity using HPLC |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105092754A true CN105092754A (en) | 2015-11-25 |
CN105092754B CN105092754B (en) | 2018-09-18 |
Family
ID=54573661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410215531.2A Active CN105092754B (en) | 2014-05-21 | 2014-05-21 | A method of measuring sulfonic acid esters genotoxicity impurity using HPLC |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105092754B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107014910A (en) * | 2016-01-27 | 2017-08-04 | 重庆华邦制药有限公司 | The separation of Apremilast and its latent gene toxic impurities and assay method |
CN107014909A (en) * | 2016-01-27 | 2017-08-04 | 重庆华邦制药有限公司 | The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method |
CN107037153A (en) * | 2017-04-21 | 2017-08-11 | 常州佳德医药科技有限公司 | The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk drugs or pharmaceutical preparation |
CN107677751A (en) * | 2017-11-03 | 2018-02-09 | 江苏开元药业有限公司 | A kind of method of high performance liquid chromatography detection Amlodipine Besylate Tablet and its impurity |
CN107782820A (en) * | 2016-08-31 | 2018-03-09 | 江苏正大丰海制药有限公司 | The assay method of genetoxic impurity ethyl p-toluenesulfonate in a kind of brufen |
CN108008024A (en) * | 2017-08-31 | 2018-05-08 | 嘉实(湖南)医药科技有限公司 | The detection method of genotoxicity impurity in doxofylline bulk pharmaceutical chemicals |
CN109212068A (en) * | 2018-09-21 | 2019-01-15 | 上海现代制药海门有限公司 | A kind of efficient liquid phase detection method of the genotoxicity impurity of Zidovudine |
CN110618219A (en) * | 2019-09-25 | 2019-12-27 | 深圳海王医药科技研究院有限公司 | Method for detecting residual solvent of trifluoromethanesulfonic acid |
CN112203738A (en) * | 2018-01-27 | 2021-01-08 | 耶拿弗里德里希·席勒大学 | Method for determining impurities in polyalkylene ethers or polyalkylene amines and use thereof |
CN111505163B (en) * | 2020-05-18 | 2021-02-12 | 上海博悦生物科技有限公司 | Method for detecting phenethyl methane sulfonate substances |
CN114487141A (en) * | 2020-10-28 | 2022-05-13 | 杭州中美华东制药有限公司 | Method for detecting genotoxic impurities in indobufen bulk drug |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005017264A (en) * | 2002-10-01 | 2005-01-20 | Kazuhiro Imai | Method of detecting/separating/identifying micro amount of expression protein/peptide, and system therefor |
CN103728404A (en) * | 2013-12-12 | 2014-04-16 | 浙江树人大学 | Method for measuring content of methylmethanesulfonate (MMS) by utilizing ion chromatography and application thereof |
-
2014
- 2014-05-21 CN CN201410215531.2A patent/CN105092754B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005017264A (en) * | 2002-10-01 | 2005-01-20 | Kazuhiro Imai | Method of detecting/separating/identifying micro amount of expression protein/peptide, and system therefor |
CN103728404A (en) * | 2013-12-12 | 2014-04-16 | 浙江树人大学 | Method for measuring content of methylmethanesulfonate (MMS) by utilizing ion chromatography and application thereof |
Non-Patent Citations (3)
Title |
---|
AMASA NAGESWARI ET AL: "A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of Ethyl p-Toluenesulfonate and Methyl p-Toluenesulfonate,T wo Potential Genotoxins in Active Pharmaceutical Ingredients", 《SCI. PHARM.》 * |
连小刚 等: "衍生气相色谱法测定甲磺酸伊马替尼中甲磺酸烷基酯类", 《中国医药科学》 * |
龚心实 等: "LC-MS/MS法检测盐酸鲁拉西酮中磺酸酯基因毒杂质", 《药学与临床研究》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107014910A (en) * | 2016-01-27 | 2017-08-04 | 重庆华邦制药有限公司 | The separation of Apremilast and its latent gene toxic impurities and assay method |
CN107014909A (en) * | 2016-01-27 | 2017-08-04 | 重庆华邦制药有限公司 | The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method |
CN107014910B (en) * | 2016-01-27 | 2021-03-12 | 重庆华邦制药有限公司 | Separation and determination method of apremilast and potential genotoxic impurities thereof |
CN107782820A (en) * | 2016-08-31 | 2018-03-09 | 江苏正大丰海制药有限公司 | The assay method of genetoxic impurity ethyl p-toluenesulfonate in a kind of brufen |
CN107037153A (en) * | 2017-04-21 | 2017-08-11 | 常州佳德医药科技有限公司 | The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk drugs or pharmaceutical preparation |
CN107037153B (en) * | 2017-04-21 | 2019-05-14 | 常州佳德医药科技有限公司 | The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk pharmaceutical chemicals or pharmaceutical preparation |
CN108008024A (en) * | 2017-08-31 | 2018-05-08 | 嘉实(湖南)医药科技有限公司 | The detection method of genotoxicity impurity in doxofylline bulk pharmaceutical chemicals |
CN107677751A (en) * | 2017-11-03 | 2018-02-09 | 江苏开元药业有限公司 | A kind of method of high performance liquid chromatography detection Amlodipine Besylate Tablet and its impurity |
CN107677751B (en) * | 2017-11-03 | 2021-04-20 | 江苏开元药业有限公司 | Method for detecting amlodipine besylate and impurities thereof by high performance liquid chromatography |
CN112203738A (en) * | 2018-01-27 | 2021-01-08 | 耶拿弗里德里希·席勒大学 | Method for determining impurities in polyalkylene ethers or polyalkylene amines and use thereof |
CN109212068A (en) * | 2018-09-21 | 2019-01-15 | 上海现代制药海门有限公司 | A kind of efficient liquid phase detection method of the genotoxicity impurity of Zidovudine |
CN110618219A (en) * | 2019-09-25 | 2019-12-27 | 深圳海王医药科技研究院有限公司 | Method for detecting residual solvent of trifluoromethanesulfonic acid |
CN110618219B (en) * | 2019-09-25 | 2022-08-19 | 深圳海王医药科技研究院有限公司 | Method for detecting residual solvent of trifluoromethanesulfonic acid |
CN111505163B (en) * | 2020-05-18 | 2021-02-12 | 上海博悦生物科技有限公司 | Method for detecting phenethyl methane sulfonate substances |
CN114487141A (en) * | 2020-10-28 | 2022-05-13 | 杭州中美华东制药有限公司 | Method for detecting genotoxic impurities in indobufen bulk drug |
Also Published As
Publication number | Publication date |
---|---|
CN105092754B (en) | 2018-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105092754A (en) | Method for determining sulfonate genotoxic impurity by using HPLC | |
CN104655751A (en) | Method for detecting residual organic solvents in dapoxetine | |
CN105891351B (en) | A kind of new Tauro ursodesoxy cholic acid content and the detection method in relation to substance | |
CN105717230A (en) | Method for detecting residual organic solvent in Favipiravir | |
CN105067724A (en) | Method for detecting organic solvent residue in Cetilistat | |
CN104237408B (en) | The detection method of compound Chlorhexidine dyclonine emulsifiable paste | |
CN103743844B (en) | The assay method of ethanol content in methyl alcohol | |
CN105092720A (en) | Method for measuring genotoxic impurities in pradaxa | |
CN102841170A (en) | Method for detecting impurity phenylhydrazine in edaravone | |
CN105929045A (en) | Method for detecting residual organic solvent in cis-atracurium besilate | |
CN106198819B (en) | The method of residual solvent in Headspace Gas Chromatography Xi Gelieting bulk pharmaceutical chemicals | |
CN105806968A (en) | Gas chromatography method for simultaneously detecting n-heptane, isooctane, ethyl acetate and isopropanol and use thereof | |
CN106033079A (en) | Method for detecting related substance imidazole in starting material F of dabigatran etexilate mesylate | |
CN104914178B (en) | Method for determining fructose and glucose in honey through high performance liquid chromatography | |
CN103645259B (en) | Method for simultaneously determining 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione and related substances thereof | |
CN105572240A (en) | Method for detecting content of pharmaceutic adjuvant carmine by using high performance liquid chromatography | |
CN102565208A (en) | Novel method for detecting etimicin sulfate | |
CN105467028A (en) | A method of separating and measuring optical isomers of a lurasidone intermediate by gas chromatography | |
CN108181386A (en) | A kind of method in relation to substance in separation determination Abiraterone acetate intermediate | |
CN101458235A (en) | Matrine liquid chromatography measuring method | |
CN104062390B (en) | The detection method of chloroform, carbon tetrachloride in chlorinated polypropylene | |
CN105277633B (en) | A kind of defects inspecting analysis method of norethindrone derivative and its intermediate | |
CN107703225A (en) | A kind of detection method for determining organic solvent residual in bromhexine hydrochloride raw material | |
CN105954431B (en) | A kind of method of the HPLC separation determination Ao Pei meter Fen bulk pharmaceutical chemicals in relation to substance | |
CN105158348A (en) | Method for determining five effective components in zedoary oil by using gas chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |